Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants

Tokiko Morita, Koji Senzaki, Ryoko Ishihara, Kazunori Umeda, Nakao Iwata, Taku Nagai, Hirotake Hida, Toshitaka Nabeshima, Kazunori Yukawa, Norio Ozaki, Yukihiro Noda

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA-S) levels are associated with remission of major depressive disorder by assessing scores on the 17-Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment. Methods Plasma DHEA-S levels in 24 patients diagnosed with major depressive disorder on the basis of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision) before and after antidepressant treatment, and 24 healthy, gender-matched, and age-matched controls were measured using a radioimmunoassay kit. Results Plasma DHEA-S levels in patients were significantly higher than those in healthy controls. In patients who achieved remission after antidepressant treatment, plasma DHEA-S levels significantly declined compared with the levels before treatment. A significant correlation was observed between changes in DHEA-S levels and Absence of Depressive and Anxious Mood scores, which are calculated from the 2-Item Structured Interview Guide for the Hamilton Depression rating as follows: severity of depressive mood and anxiety in patients before and after antidepressant treatment. Conclusions These findings suggest that plasma DHEA-S levels can be used as a putative indicator of the state of remission in patients with major depressive disorder.

Original languageEnglish
Pages (from-to)280-286
Number of pages7
JournalHuman Psychopharmacology
Volume29
Issue number3
DOIs
Publication statusPublished - 01-01-2014

Fingerprint

Dehydroepiandrosterone Sulfate
Major Depressive Disorder
Antidepressive Agents
Therapeutics
Interviews
Depression
Diagnostic and Statistical Manual of Mental Disorders
Radioimmunoassay
Anxiety

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Morita, Tokiko ; Senzaki, Koji ; Ishihara, Ryoko ; Umeda, Kazunori ; Iwata, Nakao ; Nagai, Taku ; Hida, Hirotake ; Nabeshima, Toshitaka ; Yukawa, Kazunori ; Ozaki, Norio ; Noda, Yukihiro. / Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants. In: Human Psychopharmacology. 2014 ; Vol. 29, No. 3. pp. 280-286.
@article{f5ad03edbd6b41049b6fd15c4764fd23,
title = "Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants",
abstract = "Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA-S) levels are associated with remission of major depressive disorder by assessing scores on the 17-Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment. Methods Plasma DHEA-S levels in 24 patients diagnosed with major depressive disorder on the basis of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision) before and after antidepressant treatment, and 24 healthy, gender-matched, and age-matched controls were measured using a radioimmunoassay kit. Results Plasma DHEA-S levels in patients were significantly higher than those in healthy controls. In patients who achieved remission after antidepressant treatment, plasma DHEA-S levels significantly declined compared with the levels before treatment. A significant correlation was observed between changes in DHEA-S levels and Absence of Depressive and Anxious Mood scores, which are calculated from the 2-Item Structured Interview Guide for the Hamilton Depression rating as follows: severity of depressive mood and anxiety in patients before and after antidepressant treatment. Conclusions These findings suggest that plasma DHEA-S levels can be used as a putative indicator of the state of remission in patients with major depressive disorder.",
author = "Tokiko Morita and Koji Senzaki and Ryoko Ishihara and Kazunori Umeda and Nakao Iwata and Taku Nagai and Hirotake Hida and Toshitaka Nabeshima and Kazunori Yukawa and Norio Ozaki and Yukihiro Noda",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/hup.2400",
language = "English",
volume = "29",
pages = "280--286",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants. / Morita, Tokiko; Senzaki, Koji; Ishihara, Ryoko; Umeda, Kazunori; Iwata, Nakao; Nagai, Taku; Hida, Hirotake; Nabeshima, Toshitaka; Yukawa, Kazunori; Ozaki, Norio; Noda, Yukihiro.

In: Human Psychopharmacology, Vol. 29, No. 3, 01.01.2014, p. 280-286.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants

AU - Morita, Tokiko

AU - Senzaki, Koji

AU - Ishihara, Ryoko

AU - Umeda, Kazunori

AU - Iwata, Nakao

AU - Nagai, Taku

AU - Hida, Hirotake

AU - Nabeshima, Toshitaka

AU - Yukawa, Kazunori

AU - Ozaki, Norio

AU - Noda, Yukihiro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA-S) levels are associated with remission of major depressive disorder by assessing scores on the 17-Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment. Methods Plasma DHEA-S levels in 24 patients diagnosed with major depressive disorder on the basis of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision) before and after antidepressant treatment, and 24 healthy, gender-matched, and age-matched controls were measured using a radioimmunoassay kit. Results Plasma DHEA-S levels in patients were significantly higher than those in healthy controls. In patients who achieved remission after antidepressant treatment, plasma DHEA-S levels significantly declined compared with the levels before treatment. A significant correlation was observed between changes in DHEA-S levels and Absence of Depressive and Anxious Mood scores, which are calculated from the 2-Item Structured Interview Guide for the Hamilton Depression rating as follows: severity of depressive mood and anxiety in patients before and after antidepressant treatment. Conclusions These findings suggest that plasma DHEA-S levels can be used as a putative indicator of the state of remission in patients with major depressive disorder.

AB - Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA-S) levels are associated with remission of major depressive disorder by assessing scores on the 17-Item Structured Interview Guide for the Hamilton Depression before and after antidepressant treatment. Methods Plasma DHEA-S levels in 24 patients diagnosed with major depressive disorder on the basis of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision) before and after antidepressant treatment, and 24 healthy, gender-matched, and age-matched controls were measured using a radioimmunoassay kit. Results Plasma DHEA-S levels in patients were significantly higher than those in healthy controls. In patients who achieved remission after antidepressant treatment, plasma DHEA-S levels significantly declined compared with the levels before treatment. A significant correlation was observed between changes in DHEA-S levels and Absence of Depressive and Anxious Mood scores, which are calculated from the 2-Item Structured Interview Guide for the Hamilton Depression rating as follows: severity of depressive mood and anxiety in patients before and after antidepressant treatment. Conclusions These findings suggest that plasma DHEA-S levels can be used as a putative indicator of the state of remission in patients with major depressive disorder.

UR - http://www.scopus.com/inward/record.url?scp=84898804135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898804135&partnerID=8YFLogxK

U2 - 10.1002/hup.2400

DO - 10.1002/hup.2400

M3 - Article

VL - 29

SP - 280

EP - 286

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 3

ER -